Pharmerica (PMC) Misses Q3 EPS by 7c; Guides FY16 Below Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
PharMerica Reports Third Quarter 2016 Results
November 9, 2016 8:00 AM ESTExpects Strong Fourth Quarter 2016 Results
Preliminary 2017 Guidance Within Range of Analysts Average Expectations
Company Revises 2016 Guidance
LOUISVILLE, Ky.--(BUSINESS WIRE)-- PharMerica Corporation (the Corporation or the Company) (NYSE: PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today reported its financial results for the third quarter ended September 30, 2016.
       3Q16 Results ÂComparison to3Q15
ÂComparison to2Q16
Revenue   $512.6 million  Increase of 2.8%  Decrease of 1.3% Gross profit  ... More